Abstract
Background: ST-elevation myocardial infarction (STEMI) occurs due to acute occlusion of a coronary artery which require urgent intervention to avoid morbidity and mortality. In patients with acute STEMI, cardiogenic shock is the leading cause of death. STEMI outcomes has improved significantly in the past few decades due to the advancement of different methods of acute myocardial infarction management plans. Therefore, we aim in this review to discuss the management of STEMI and the controversies mentioned in literature.
Objective: A lot of literature have been done in order to provide better outcomes for patients presented with Myocardial Infarction, in our review we aim to discuss the recent literature that discussed Myocardial Infarction diagnosis and management.
Methods: A lot of literature have been done in order to provide better outcomes for patients presented with Myocardial Infarction, in our review we aim to discuss the recent literature that discussed myocardial infarction management.
Conclusion: Prompt and effective reperfusion therapy is the cornerstone of treatment for acute STEMI and is the only widely applicable acute treatment to diminish infarct size and major cardiac complications. Primary PCI is therefore the preferred strategy for patients with acute ST elevation MI. Fibrin-specific agents in combination with parenteral anticoagulants offer the highest level of efficacy in terms of short-term mortality reduction in patients with STEMI. Dual antiplatelet therapy reduced the 1-year incidence of cardiovascular events by approximately 20% compared with aspirin alone. Recent studies suggested that oxygen may do more harm than good and results in a greater infarct size and possibly increase the risk of mortality.